| scholarly article | Q13442814 |
| P50 | author | Markus A Seeliger | Q56891944 |
| Ron Ofer Dror | Q59678272 | ||
| P2093 | author name string | David E Shaw | |
| Michael P Eastwood | |||
| Eric T Kim | |||
| Yibing Shan | |||
| P2860 | cites work | A conserved protonation-dependent switch controls drug binding in the Abl kinase | Q24657421 |
| Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc | Q27655577 | ||
| Crystal structure of the Src family tyrosine kinase Hck | Q27734750 | ||
| Funnels, pathways, and the energy landscape of protein folding: a synthesis | Q29617521 | ||
| Protein kinases: evolution of dynamic regulatory proteins | Q30014836 | ||
| Motifs for molecular recognition exploiting hydrophobic enclosure in protein-ligand binding | Q35612259 | ||
| Blind docking of drug-sized compounds to proteins with up to a thousand residues | Q40352786 | ||
| Just add water! The effect of water on the specificity of protein-ligand binding sites and its potential application to drug design | Q41318459 | ||
| Blind docking of pharmaceutically relevant compounds using RosettaLigand | Q42637708 | ||
| Energy landscape theory, funnels, specificity, and optimal criterion of biomolecular binding | Q73478247 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 9181-9183 | |
| P577 | publication date | 2011-05-13 | |
| P1433 | published in | Journal of the American Chemical Society | Q898902 |
| P1476 | title | How does a drug molecule find its target binding site? | |
| P478 | volume | 133 |
| Q39213631 | A Hidden Active Site in the Potential Drug Target Mycobacterium tuberculosis dUTPase Is Accessible through Small Amplitude Protein Conformational Changes |
| Q42381285 | A Quantitative Model for cAMP Binding to the Binding Domain of MloK1. |
| Q35156745 | A coarse-grained elastic network atom contact model and its use in the simulation of protein dynamics and the prediction of the effect of mutations |
| Q35687060 | A drug-specific nanocarrier design for efficient anticancer therapy |
| Q42380933 | A fast, open source implementation of adaptive biasing potentials uncovers a ligand design strategy for the chromatin regulator BRD4. |
| Q34402706 | ALiBERO: Evolving a Team of Complementary Pocket Conformations Rather than a Single Leader |
| Q36282684 | Accelerated flexible protein-ligand docking using Hamiltonian replica exchange with a repulsive biasing potential |
| Q33699049 | Accelerated molecular dynamics simulations of ligand binding to a muscarinic G-protein-coupled receptor |
| Q57168288 | Acceleration of biomolecular kinetics in Gaussian accelerated molecular dynamics |
| Q36520871 | Accounting for receptor flexibility and enhanced sampling methods in computer-aided drug design |
| Q47163259 | Adaptive Multilevel Splitting Method for Molecular Dynamics Calculation of Benzamidine-Trypsin Dissociation Time |
| Q41436607 | Adaptive simulations, towards interactive protein-ligand modeling |
| Q38800768 | Advanced molecular dynamics simulation methods for kinase drug discovery |
| Q38698407 | Advances in free-energy-based simulations of protein folding and ligand binding. |
| Q41815533 | Allosteric Communication Networks in Proteins Revealed through Pocket Crosstalk Analysis |
| Q98178435 | Allosteric Regulation at the Crossroads of New Technologies: Multiscale Modeling, Networks, and Machine Learning |
| Q38948740 | Application of Hidden Markov Models in Biomolecular Simulations. |
| Q35663714 | Assessing the potential of atomistic molecular dynamics simulations to probe reversible protein-protein recognition and binding |
| Q41969921 | Atomic and dynamic insights into the beneficial effect of the 1,4-naphthoquinon-2-yl-L-tryptophan inhibitor on Alzheimer's Aβ1-42 dimer in terms of aggregation and toxicity. |
| Q39264801 | Atomic level rendering of DNA-drug encounter. |
| Q55093077 | Atomic resolution mechanism of ligand binding to a solvent inaccessible cavity in T4 lysozyme. |
| Q38918905 | Binding Kinetics in Drug Discovery |
| Q55476262 | Binding Modes of Ligands Using Enhanced Sampling (BLUES): Rapid Decorrelation of Ligand Binding Modes via Nonequilibrium Candidate Monte Carlo. |
| Q34254661 | Binding site multiplicity with fatty acid ligands: implications for the regulation of PKR kinase autophosphorylation with palmitate |
| Q36009999 | Bioinformatics and variability in drug response: a protein structural perspective |
| Q52331594 | Biomolecular conformational changes and ligand binding: from kinetics to thermodynamics |
| Q58719254 | Bridging Molecular Docking to Molecular Dynamics in Exploring Ligand-Protein Recognition Process: An Overview |
| Q30362300 | Bringing Clarity to the Prediction of Protein-Ligand Binding Free Energies via "Blurring" |
| Q35181207 | Can structural features of kinase receptors provide clues on selectivity and inhibition? A molecular modeling study |
| Q28484330 | Can the Energy Gap in the Protein-Ligand Binding Energy Landscape Be Used as a Descriptor in Virtual Ligand Screening? |
| Q41547898 | Cloud computing approaches for prediction of ligand binding poses and pathways. |
| Q37697030 | Collective variable approaches for single molecule flexible fitting and enhanced sampling |
| Q38674854 | Combining experimental and simulation data of molecular processes via augmented Markov models. |
| Q83987488 | Comparative Study of Flavins Binding with Human Serum Albumin: A Fluorometric, Thermodynamic, and Molecular Dynamics Approach |
| Q57975272 | Computational Approaches for Studying Drug Binding Kinetics |
| Q33631185 | Computational analysis of the binding specificity of Gleevec to Abl, c-Kit, Lck, and c-Src tyrosine kinases |
| Q26746941 | Computational approaches in target identification and drug discovery |
| Q50739068 | Computational gibberellin‐binding channel discovery unraveling the unexpected perception mechanism of hormone signal by gibberellin receptor |
| Q26997089 | Computational methods in drug discovery |
| Q52620670 | Conformational dynamics of capping protein and interaction partners: simulation studies |
| Q30607614 | Conformational response to ligand binding in phosphomannomutase2: insights into inborn glycosylation disorder. |
| Q38363774 | Conformational selection or induced fit? 50 years of debate resolved |
| Q34440071 | Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors |
| Q37377393 | Construction of Metabolism Prediction Models for CYP450 3A4, 2D6, and 2C9 Based on Microsomal Metabolic Reaction System |
| Q36553939 | Coupled folding and binding with 2D Window-Exchange Umbrella Sampling. |
| Q30667813 | Critical role of water in the binding of volatile anesthetics to proteins. |
| Q39757397 | Derivation of fixed partial charges for amino acids accommodating a specific water model and implicit polarization |
| Q28546662 | DnaK as Antibiotic Target: Hot Spot Residues Analysis for Differential Inhibition of the Bacterial Protein in Comparison with the Human HSP70 |
| Q30928104 | Dominant Alcohol-Protein Interaction via Hydration-Enabled Enthalpy-Driven Binding Mechanism |
| Q47374327 | Dynamic Docking: A Paradigm Shift in Computational Drug Discovery |
| Q34442244 | Dynamic architecture of a protein kinase. |
| Q47146818 | Dynamic changes in binding interaction networks of sex steroids establish their non-classical effects |
| Q36053324 | E-pharmacophore-based virtual screening to identify GSK-3β inhibitors |
| Q27301215 | Efficient Atomistic Simulation of Pathways and Calculation of Rate Constants for a Protein-Peptide Binding Process: Application to the MDM2 Protein and an Intrinsically Disordered p53 Peptide |
| Q38128326 | Electron transfer in proteins: theory, applications and future perspectives. |
| Q92882026 | Encounter complexes and hidden poses of kinase-inhibitor binding on the free-energy landscape |
| Q47110210 | Energetics of Glutamate Binding to an Ionotropic Glutamate Receptor. |
| Q88055732 | Escape of a Small Molecule from Inside T4 Lysozyme by Multiple Pathways |
| Q37538547 | Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer |
| Q39257749 | Evaluation of protein-ligand affinity prediction using steered molecular dynamics simulations |
| Q36582978 | Explaining why Gleevec is a specific and potent inhibitor of Abl kinase |
| Q36342813 | Exploration of gated ligand binding recognizes an allosteric site for blocking FABP4-protein interaction |
| Q36184063 | Exploring the Molecular Interactions of 7,8-Dihydroxyflavone and Its Derivatives with TrkB and VEGFR2 Proteins |
| Q27001129 | Exploring the role of receptor flexibility in structure-based drug discovery |
| Q47567885 | Finding the needle in the haystack: towards solving the protein-folding problem computationally. |
| Q31033753 | Flexibility and binding affinity in protein-ligand, protein-protein and multi-component protein interactions: limitations of current computational approaches. |
| Q38574930 | Flexible receptor docking for drug discovery |
| Q39338318 | Fluorescence polarization assay for inhibitors of the kinase domain of receptor interacting protein 1 |
| Q38035239 | From base pair to bedside: molecular simulation and the translation of genomics to personalized medicine. |
| Q35655672 | Functional-segregated coumarin-containing telodendrimer nanocarriers for efficient delivery of SN-38 for colon cancer treatment |
| Q30539051 | Funnel metadynamics as accurate binding free-energy method |
| Q58080237 | Gaussian accelerated molecular dynamics for elucidation of drug pathways |
| Q51759998 | Genome-based approaches to develop epitope-driven subunit vaccines against pathogens of infective endocarditis. |
| Q34457250 | High-Throughput parallel blind Virtual Screening using BINDSURF. |
| Q24614202 | Highly specific, bisubstrate-competitive Src inhibitors from DNA-templated macrocycles |
| Q41965081 | How and when does an anticancer drug leave its binding site? |
| Q37103848 | How hydrophobic drying forces impact the kinetics of molecular recognition |
| Q42377074 | How wet should be the reaction coordinate for ligand unbinding? |
| Q30413750 | Identification of Domains in Protein Structures from the Analysis of Intramolecular Interactions |
| Q97905427 | Identification of key interactions between SARS-CoV-2 main protease and inhibitor drug candidates |
| Q30409188 | Identifying ligand binding sites and poses using GPU-accelerated Hamiltonian replica exchange molecular dynamics |
| Q37280290 | Improved estimation of protein-ligand binding free energy by using the ligand-entropy and mobility of water molecules |
| Q48044225 | Incorporating specificity into optimization: evaluation of SPA using CSAR 2014 and CASF 2013 benchmarks |
| Q47671310 | Insights into the crystal structure of BRD2-BD2 - phenanthridinone complex and theoretical studies on phenanthridinone analogs. |
| Q93200291 | Integrating Ligand and Target-Driven Based Virtual Screening Approaches With in vitro Human Cell Line Models and Time-Resolved Fluorescence Resonance Energy Transfer Assay to Identify Novel Hit Compounds Against BCL-2 |
| Q58769381 | Intriguing role of water in protein-ligand binding studied by neutron crystallography on trypsin complexes |
| Q39244737 | Kinetics for Drug Discovery: an industry-driven effort to target drug residence time |
| Q30655357 | Kinetics of protein-ligand unbinding via smoothed potential molecular dynamics simulations |
| Q51604998 | Let's get honest about sampling. |
| Q49374902 | Ligand Binding Pathways and Conformational Transitions of the HIV Protease |
| Q51083348 | Ligand entry into the calyx of β-lactoglobulin. |
| Q57794695 | Ligand selection from the analysis of protein conformational substates: new leads targeting the N-terminal domain of Hsp90 |
| Q41283780 | Limiting assumptions in molecular modeling: electrostatics |
| Q35887173 | Locating binding poses in protein-ligand systems using reconnaissance metadynamics |
| Q38970269 | Lumican Peptides: Rational Design Targeting ALK5/TGFBRI. |
| Q57489745 | Mapping the Ligand Binding Landscape |
| Q26827934 | Markov state models of biomolecular conformational dynamics |
| Q33879450 | Mechanism of the Association Pathways for a Pair of Fast and Slow Binding Ligands of HIV-1 Protease. |
| Q62515266 | Metal–ligand interactions in drug design |
| Q47676752 | Mobility-based prediction of hydration structures of protein surfaces |
| Q36175542 | Modeling molecular kinetics with tICA and the kernel trick |
| Q91588369 | Molecular Dynamics Simulation for All |
| Q91452095 | Molecular Dynamics Simulation reveals the mechanism by which the Influenza Cap-dependent Endonuclease acquires resistance against Baloxavir marboxil |
| Q27316278 | Molecular Dynamics of "Fuzzy" Transcriptional Activator-Coactivator Interactions |
| Q30658298 | Molecular basis for pseudokinase-dependent autoinhibition of JAK2 tyrosine kinase |
| Q41227055 | Molecular dynamics analysis to evaluate docking pose prediction |
| Q40844559 | Molecular dynamics of sialic acid analogues complex with cholera toxin and DFT optimization of ethylene glycol-mediated zinc nanocluster conjugation |
| Q34061019 | Molecular dynamics simulations and drug discovery |
| Q90703205 | Molecular insights into the interaction of hemorphin and its targets |
| Q41443980 | Molecular modeling of methyl-α-Neu5Ac analogues docked against cholera toxin--a molecular dynamics study. |
| Q43563984 | Molecular simulation of N-acetylneuraminic acid analogs and molecular dynamics studies of cholera toxin-Neu5Gc complex |
| Q47952207 | Multiple Ligand Unbinding Pathways and Ligand-Induced Destabilization Revealed by WExplore |
| Q35822656 | Multiscale Estimation of Binding Kinetics Using Brownian Dynamics, Molecular Dynamics and Milestoning |
| Q91165293 | Nontargeted Parallel Cascade Selection Molecular Dynamics Based on a Nonredundant Selection Rule for Initial Structures Enhances Conformational Sampling of Proteins |
| Q39226865 | Novel approaches for targeting kinases: allosteric inhibition, allosteric activation and pseudokinases |
| Q61817296 | On identifying collective displacements in apo-proteins that reveal eventual binding pathways |
| Q36654358 | On the interaction mechanisms of a p53 peptide and nutlin with the MDM2 and MDMX proteins: a Brownian dynamics study. |
| Q24321210 | Oncogenic mutations counteract intrinsic disorder in the EGFR kinase and promote receptor dimerization |
| Q30431383 | PELE web server: atomistic study of biomolecular systems at your fingertips |
| Q30503489 | Pathway and mechanism of drug binding to G-protein-coupled receptors. |
| Q35578839 | Peptide Binding to a PDZ Domain by Electrostatic Steering via Nonnative Salt Bridges |
| Q40458411 | Peptoid nanosheets exhibit a new secondary-structure motif. |
| Q36502439 | Pocket-based drug design: exploring pocket space |
| Q83615387 | Potential Selective Inhibitors against Rv0183 of Mycobacterium tuberculosis Targeting Host Lipid Metabolism |
| Q47625069 | Prediction of binding poses to FXR using multi-targeted docking combined with molecular dynamics and enhanced sampling. |
| Q26749162 | Principles and Overview of Sampling Methods for Modeling Macromolecular Structure and Dynamics |
| Q97692526 | Protein-ligand binding with the coarse-grained Martini model |
| Q57160189 | Quantitative Ranking of Ligand Binding Kinetics with a Multiscale Milestoning Simulation Approach |
| Q49596794 | RNA force field with accuracy comparable to state-of-the-art protein force fields |
| Q39219062 | Rate Constants and Mechanisms of Protein-Ligand Binding |
| Q36795631 | Rational prediction with molecular dynamics for hit identification |
| Q39152860 | Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors |
| Q47291097 | Relative Binding Free Energy Calculations in Drug Discovery: Recent Advances and Practical Considerations |
| Q26747130 | Revealing Atomic-Level Mechanisms of Protein Allostery with Molecular Dynamics Simulations |
| Q34680443 | Role of Desolvation in Thermodynamics and Kinetics of Ligand Binding to a Kinase |
| Q51602802 | Role of the Biomolecular Energy Gap in Protein Design, Structure, and Evolution |
| Q36120365 | Role of water and steric constraints in the kinetics of cavity-ligand unbinding |
| Q34300133 | Routine Access to Millisecond Time Scale Events with Accelerated Molecular Dynamics |
| Q48247516 | SEEKR: Simulation Enabled Estimation of Kinetic Rates, A Computational Tool to Estimate Molecular Kinetics and Its Application to Trypsin-Benzamidine Binding. |
| Q37680855 | Seeking structural specificity: direct modulation of pentameric ligand-gated ion channels by alcohols and general anesthetics. |
| Q50583541 | Simulation of macromolecular liquids with the adaptive resolution molecular dynamics technique |
| Q60960514 | Solvents to Fragments to Drugs: MD Applications in Drug Design |
| Q35819956 | Specificity quantification of biomolecular recognition and its implication for drug discovery |
| Q91235937 | Spontaneous Ligand Access Events to Membrane-Bound Cytochrome P450 2D6 Sampled at Atomic Resolution |
| Q37277307 | Statistical estimation of the protein-ligand binding free energy based on direct protein-ligand interaction obtained by molecular dynamics simulation |
| Q30423438 | Structural and dynamic determinants of protein-peptide recognition |
| Q50470980 | Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs. |
| Q28541379 | Structure-based druggability assessment of the mammalian structural proteome with inclusion of light protein flexibility |
| Q35282223 | Structure-based virtual screening for drug discovery: principles, applications and recent advances. |
| Q34038269 | Substrate binding process and mechanistic functioning of type 1 11β-hydroxysteroid dehydrogenase from enhanced sampling methods |
| Q61811864 | Surface Binding Energy Landscapes Affect Phosphodiesterase Isoform-Specific Inhibitor Selectivity |
| Q47250664 | Systematic exploration of multiple drug binding sites |
| Q47448946 | The BioFragment Database (BFDb): An open-data platform for computational chemistry analysis of noncovalent interactions. |
| Q38061633 | The Role of Molecular Simulations in the Development of Inhibitors of Amyloid β-Peptide Aggregation for the Treatment of Alzheimer’s Disease |
| Q47292153 | The bioactive protein-ligand conformation of GluN2C-selective positive allosteric modulators bound to the NMDA receptor. |
| Q44679907 | The creation of proton hopping from a drug-receptor encounter |
| Q34241696 | The future of molecular dynamics simulations in drug discovery |
| Q30618624 | The ligand binding mechanism to purine nucleoside phosphorylase elucidated via molecular dynamics and machine learning. |
| Q33707352 | Treating sickle cell disease by targeting HbS polymerization |
| Q30008744 | Tyrosine Kinase Activation and Conformational Flexibility: Lessons from Src-Family Tyrosine Kinases. |
| Q53510547 | Understanding selective molecular recognition in integrated carbon nanotube-polymer sensors by simulating physical analyte binding on carbon nanotube-polymer scaffolds |
| Q41996825 | Unveiling prolyl oligopeptidase ligand migration by comprehensive computational techniques. |
| Q34787480 | VinaMPI: facilitating multiple receptor high-throughput virtual docking on high-performance computers. |
| Q47400859 | Virtual identification of novel PPARα/γ dual agonists by scaffold hopping of saroglitazar |
| Q45096401 | Why is F19Ap53 unable to bind MDM2? Simulations suggest crack propagation modulates binding. |
Search more.